Video
Audio
Ivermectin Studies Censored by Medical Journals. Med Journals Drive Fear-Virus-Vaccine Narratives. Dr. Pierre Kory, Covid19CriticalCare.com
211 views • 11/21/2022

Positive Ivermectin Studies Actively Rejected and Censored by High Impact Medical Journals.

FULL SHOW: Dr. Pierre Kory Interview by The New American, 2022,  https://rumble.com/v1kzn29-dr.-pierre-kory-high-impact-journals-censoring-ivermectin-studies.html

Dr. Pierre Kory: "Ivermectin is my first line and mainstay for long haulers. It is the most frequently effective therapy." More on the main mechanisms of action for Ivermectin. ~ www.covid19criticalcare.com

"The outcome could have been much different - and many lives saved - if Big Pharma hadn’t been so successful at suppressing this generic pharmaceutical that was found to work against COVID-19." ~ drJosephMercola.com

All About Ivermectin: www.EnergyMe333.com/articles/healthCancerIvermectin.html

In his book, “The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the COVID Pandemic,” Dr. Pierre Kory details the history of ivermectin and the how and why behind Big Pharma’s suppression of this drug when it was found to work against COVID-19" ~ www.drJosephMercola.com

"Pierre Kory, MD, MPA, is the former Chief of the Critical Care Service and Medical Director of the Trauma and Life Support Center at the University of Wisconsin. He is considered one of the world pioneers in the use of ultrasound by physicians in the diagnosis and treatment of critically ill patients." ~ www.covid19criticalcare.com


Keywords
FREE email alerts of the most important BANNED videos in the world
Get FREE email alerts of the most important BANNED videos in the world that are usually blacklisted by YouTube, Facebook, Google, Twitter and Vimeo. Watch documentaries the techno-fascists don't want you to know even exist. Join the free Brighteon email newsletter. Unsubscribe at any time. 100% privacy protected.
Your privacy is protected. Subscription confirmation required.
100 videos 22:28:52Public